Oxfords COVID-19 Vaccine Trial Begins in Britain

Dec, 2020 - By WMR

Oxfords COVID-19 Vaccine Trial Begins in Britain

The ongoing Phase III clinical trial spans five continents such as Brazil, India, South Africa, the United States, and the United Kingdom.

The novel coronavirus (COVID-19 pandemic) has made its way to almost every corner of the world and has infected millions of people worldwide. As the disease wreaks havoc in health care systems around the world, a myriad of strategies is currently being tested to curb the spread of the virus or to combat the virus. Research institutes and Pharma companies are trying to develop a safe and effective drug or vaccine to combat the virus. As of now (September 14), the virus has infected more than 29 million people and killed more than 932,461 individuals across the globe.

AstraZeneca (a British-Swedish pharmaceutical company) and the University of Oxford have developed a potential COVID-19 vaccine named AZD1222 (ChAdOx1 nCoV-19) to combat the virus. On September 6, 2020, On September 6, 2020, a Phase III clinical trial of Oxford’s COVID-19 vaccine was stopped after a standard review identified serious adverse reaction in a participant in the United Kingdom. However, now, after an independent investigation by the Medicines Health Regulatory Authority (MHRA), Phase III clinical trials of Oxford’s COVID-19 vaccine are resumed in the U.K.

In July 2020, the team confirmed that the vaccine candidate has moved to the phase III clinical trial in the United Kingdom. Exactly what the reaction is and when it occurred has not yet been made public, however, the report states that the patient is expected to recover. Around 18,000 people worldwide have received study vaccines as part of the trial. According to the University of Oxford, in such large trials, some participants are expected to become unwell, as well as every case needs to be carefully evaluated to ensure their safety. The public roll-out of Oxford’s COVID-19 vaccine is expected to begin in the first half of 2021.

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Contact us

Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.


Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.


Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection


© 2021 Worldwide Market Reports. All rights reserved